West Pharma (WST) Misses Q3 EPS by 10c; Offers FY22 Revenue Guidance
Go back to West Pharma (WST) Misses Q3 EPS by 10c; Offers FY22 Revenue Guidance| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 360.48 -6.12 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.60 | 52 Week High | $84.33 | |||
| Open | $366.59 | 52 Week Low | $53.88 | |||
| Day High | $366.86 | P/E | 229.61 | |||
| Day Low | $359.52 | EPS | $1.57 | |||
| Volume | 310,068 | |||||
